News

Weiss-Kruszka syndrome is a rare neurodevelopmental disorder characterized by craniofacial anomalies, developmental delay, and autistic features.…

05 Jan'23

Nuclear pore complexes (NPCs) are the gateways between the nucleus and the cytoplasm. How the individual components assemble into a functional…

21 Dec'22

Plasma cells are the antibody factory or our immune system: they secrete vast quantities of highly specialised antibodies to counter an infection. IMP…

19 Dec'22

The Austrian Society for Dermatology and Venereology presents the yearly Science Award to scientists whose recent publications answer far-reaching…

15 Dec'22

The Paul G. Allen Frontiers Group has announced its 2022 selection of Allen Distinguished Investigators. Among the selected researchers is IMP Senior…

14 Dec'22

invIOs announced that CEO Peter Llewellyn-Davies will present a corporate update during the upcoming Biotech Showcase 2023 meeting in January.

07 Dec'22

The Austrian Science Fund FWF has allocated €2 million in funding to a joint doc.funds initiative coordinated by Javier Martinez. The course will…

05 Dec'22

Valneva reported positive antibody persistence data twelve months after vaccination with a single dose of its chikungunya vaccine candidate, VLA1553.

…

01 Dec'22

Valneva and Pfizer today reported antibody persistence data six months after the completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6)…

28 Nov'22

Group leader Sebastian Falk has been named a ‘Young Investigator’ for the next four years by the European Molecular Biology Organization (EMBO). The…

24 Nov'22

Researchers from the Tachibana lab show that the pioneer factor Nr5a2 can awaken the inactive genome in the early embryo. Part of this work was…

22 Nov'22

Two ERC Starting Grants were granted to two female group leaders at the Vienna BioCenter. IMBA researcher Joanna Jachowicz will investigate how the…

Weiss-Kruszka syndrome and the failure to establish neuronal identity

Punching holes in the nucleus

Avoiding the flood: how plasma cells constrain antibody secretion

Clinical dermatology award for Lukas Leiendecker

Tim Clausen among Allen Distinguished Investigators 2022

invIOs to present at Biotech Showcase

FWF awards doc.funds and stand alone project grants

Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate

Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate

Sebastian Falk joins EMBO Young Investigator program

Awakening the genome

ERC Starting Grants for Joanna Jachowicz and Kelly Swarts